At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PYPD PolyPid Ltd.
Closed Good Friday 04-17 16:00:00 EDT
2.74
-0.01
-0.36%
| High2.76 | Low2.74 | Vol2.38K |
| Open2.75 | D1 Closing2.75 | Amplitude0.86% |
| Mkt Cap27.92M | Tradable Cap12.58M | Total Shares10.19M |
| T/O6.54K | T/O Rate0.05% | Tradable Shares4.59M |
| P/B-- | ROE-- | EPS0.00 |
| 52wk High-- | 52wk Low-- | P/E-- |
| Dividend-- | Div.Yield-- | ROA-- |
Loading ...
PolyPid Price Target Maintained With a $11.00/Share by HC Wainwright & Co.
Dow Jones · 04-14
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
ACCESS Newswire · 03-18
PolyPid’s Promising Outlook: Buy Rating Affirmed Amidst SHIELD II Trial Progress and Strategic FDA Engagement
TIPRANKS · 03-11
PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
GlobeNewswire · 03-11
PolyPid to Participate in the 37th Annual ROTH Conference
GlobeNewswire · 03-03
PolyPid Ltd (PYPD) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising R&D Costs
GuruFocus.com · 02-13
PolyPid (PYPD) Gets a Buy from JMP Securities
TIPRANKS · 02-12
BUZZ-PolyPid falls on wider-than-expected quarterly loss
Reuters · 02-12
PolyPid Ltd reports results for the quarter ended December 31 - Earnings Summary
Reuters · 02-12
PolyPid Updates: New Board Appointment and SHIELD II Trial Progress
TIPRANKS · 02-12
PolyPid Q4 2024 GAAP EPS $(1.13) Misses $(0.82) Estimate; Cash $15.6M
Benzinga · 02-12
PolyPid Ltd Qtrly EPS $-1.13
THOMSON REUTERS · 02-12
PolyPid Ltd expected to post a loss of 88 cents a share - Earnings Preview
Reuters · 02-10
PolyPid Ltd Files for Resale of up to 11.23 Mln Ordinary Shares by the Selling Shareholders - SEC Filing
THOMSON REUTERS · 01-21
PolyPid Regains Nasdaq Compliance with Private Placement Boost
TIPRANKS · 01-17
HC Wainwright Adjusts Price Target on PolyPid to $11 From $14, Keeps Buy Rating
MT Newswires Live · 2024-12-27
PolyPid Advances Phase 3 Trial and Secures Financing
TIPRANKS · 2024-12-26
PolyPid Ltd : H.c. Wainwright Cuts Target Price to $11 From $14
THOMSON REUTERS · 2024-12-26
PolyPid price target lowered to $11 from $14 at H.C. Wainwright
TIPRANKS · 2024-12-26
PolyPid Down 19% After Study Update, Private Placement
Dow Jones · 2024-12-24
Introduction
Company Name.
PolyPid Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--
Invest in Global Markets with Tiger Brokers!Open App